Danoprevir
CAS No. 850876-88-9
Danoprevir ( ITMN-191;R-7227;RO-5190591;RG-7227 )
产品货号. M16181 CAS No. 850876-88-9
A potent, highly selective, orally available, peptidomimetic HCV NS3/4A protease inhibitor with IC50 of 0.2-0.4 nM (GT1a, 1b, 4, 5 and 6), 1.6 nM (GT2b).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1126 | 有现货 |
|
10MG | ¥2001 | 有现货 |
|
25MG | ¥3418 | 有现货 |
|
50MG | ¥5071 | 有现货 |
|
100MG | ¥7201 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Danoprevir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A potent, highly selective, orally available, peptidomimetic HCV NS3/4A protease inhibitor with IC50 of 0.2-0.4 nM (GT1a, 1b, 4, 5 and 6), 1.6 nM (GT2b).
-
产品描述A potent, highly selective, orally available, peptidomimetic HCV NS3/4A protease inhibitor with IC50 of 0.2-0.4 nM (GT1a, 1b, 4, 5 and 6), 1.6 nM (GT2b); shows favorable potency profile against multiple HCV genotypes 1–6 and key mutants (replicon GT1b, EC50=1.6 nM).HCV Infection Approved
-
同义词ITMN-191;R-7227;RO-5190591;RG-7227
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCVNS3/4Aprotease
-
研究领域Infection
-
适应症HCV Infection
化学信息
-
CAS Number850876-88-9
-
分子量731.83
-
分子式C35H46FN5O9S
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(N1CC2=C(C(F)=CC=C2)C1)O[C@@H](C3)C[C@](C(N[C@@](C4)(C(NS(=O)(C5CC5)=O)=O)[C@]4([H])/C=C\CCCCCC6NC(OC(C)(C)C)=O)=O)([H])N3C6=O
-
化学全称2H-Isoindole-2-carboxylic acid, 4-fluoro-1,3-dihydro-, (2R,6S,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a]
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Bae A, et al. Antimicrob Agents Chemother. 2010 Dec;54(12):5288-97.
2. Moucari R, et al. Gut. 2010 Dec;59(12):1694-8.
3. Jiang Y, et al. J Med Chem. 2014 Mar 13;57(5):1753-69.
4. Schaefer CJ, et al. Antimicrob Agents Chemother. 2011 Jul;55(7):3125-32.
2. Moucari R, et al. Gut. 2010 Dec;59(12):1694-8.
3. Jiang Y, et al. J Med Chem. 2014 Mar 13;57(5):1753-69.
4. Schaefer CJ, et al. Antimicrob Agents Chemother. 2011 Jul;55(7):3125-32.
产品手册
关联产品
-
Sofosbuvir impurity ...
Sofosbuvir impurity F is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
-
Voxilaprevir
Voxilaprevir (GS-9857)is a potent HCV NS3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.
-
Beclabuvir hydrochlo...
Beclabuvir (BMS-791325) is a potent allosteric inhibitor of HCV NS5B polymerase with EC50 of 6 and 3 nM for genotype 1b and 1a in FRET assays, respectively.